Open
SectorHealthcare
8.55 1.79
24h
Min
8.33
Max
8.98
Income | 57M 6.1M |
---|---|
Sales | 68M 89M |
EPS | 0.12 |
Profit margin | 6.834 |
Employees | 353 |
EBITDA | 50M 12M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +291.43% upside |
Next Earnings | 31 lip 2025 |
---|
Market Cap | -3.4M 396M |
---|---|
Previous open | 6.76 |
Previous close | 8.55 |
By Acuity
100%
0%
366 / 380 Ranking in Healthcare
By Trading Central
Confidence
Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 34.25 USD 291.43%
High 50 USD
Low 22 USD
Based on 10 Wall Street analysts offering 12 month price targets forREGENXBIO Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Very Strong Bearish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$